A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1997
10/30/1997	CA2251584A1 Autoantigen and proteins structurally related thereto for use in immunotherapy of autoimmune diseases
10/30/1997	CA2251356A1 Component b as cicatrizant
10/30/1997	CA2250921A1 Modified ligands of calcium-dependent binding proteins
10/30/1997	CA2250869A1 Combination therapy for treatment of erectile dysfunction
10/30/1997	CA2250431A1 Al-2 neurotrophic factor
10/30/1997	CA2250425A1 Novel protein - traf6
10/29/1997	EP0803570A1 Mutant human insulin receptor dna
10/29/1997	EP0803511A1 Allergenic proteins from ragweed and uses therefor
10/29/1997	EP0803256A1 Drug for relieving side effects caused by immunosuppressants
10/29/1997	EP0803255A1 Medicinal composition
10/29/1997	EP0802986A1 Methods of determining endogenous thrombin potential (etp) and thrombin substrates for use in said methods
10/29/1997	EP0802985A1 Cell cycle regulated repressor and dna element
10/29/1997	EP0802984A1 Use of prolactin for preventing and/or treating bird broodiness
10/29/1997	EP0802983A2 Expression of urokinase plasminogen activator inhibitors
10/29/1997	EP0802976A2 Stabilized external guide sequences
10/29/1997	EP0802972A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
10/29/1997	EP0802923A1 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors
10/29/1997	EP0802922A1 Novel amino acid derivatives, method of producing them and pharmaceutical compositions containing these compounds
10/29/1997	EP0802921A1 Human pak65
10/29/1997	EP0802916A1 Low molecular weight bicyclic thrombin inhibitors
10/29/1997	EP0802909A2 Substituted oxazolidine calpain and/or cathepsin b inhibitors
10/29/1997	EP0802801A2 Methods and compositions for treatment of solid tumors in vivo
10/29/1997	EP0802800A2 Improved compositions and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
10/29/1997	EP0802797A1 Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis
10/29/1997	EP0802795A1 Neurological drug screens
10/29/1997	EP0802792A1 Therapeutic treatment for inhibiting vascular restenosis
10/29/1997	EP0802784A1 Nutrient medium for use as a culture medium for epidermal cells, and uses thereof
10/29/1997	EP0672063B1 Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody
10/29/1997	EP0493380B1 Method and compositions for noninvasive dose-to-effect administration of lipophilic drugs
10/29/1997	EP0116571B2 Method for making gamma globulin-containing compositions
10/29/1997	CN1163656A Axial flow valve system for linear compressor
10/29/1997	CN1163635A Macrophage derived chemokine and chemokine analogs
10/29/1997	CN1163620A Gradual modification super-agonists and antagonists of signal-proteins and peptides
10/29/1997	CN1163619A Antigenic polypeptide of chlamydia pneumoniae
10/29/1997	CN1163618A Urokinase receptor ligands
10/29/1997	CN1163575A Immunogenic compositions
10/29/1997	CN1163574A Acylated insulin analogs
10/29/1997	CN1163573A Pharmaceutical compositions containing bile salt and buffer for increased bioavailability of active compound
10/29/1997	CN1163572A Treatment of type B diabetes mellitus with anylin agonists
10/29/1997	CN1163571A Compositions containing at least one glucocorticoid in combination with pulmonary surfactant for treatment of IRDS and ARDS
10/29/1997	CN1163145A Inhibiting agent for vascular formation
10/29/1997	CN1163137A Soft extract for curing scald
10/29/1997	CN1163055A Anti-senility health oil eries product and its use
10/28/1997	US5681944 Hybridizes with the translation initiation region of the e6 or e7 messanger rna of human papilloma virus such that replication of virus is inhibited
10/28/1997	US5681941 Substituted purines and oligonucleotide cross-linking
10/28/1997	US5681933 Immunizing animal with interleukin
10/28/1997	US5681930 Genetic engineering; capable of binding
10/28/1997	US5681928 Acylation, alkylation of an aminoglycine; insertion into peptide
10/28/1997	US5681925 Trifunctional antithrombin and antiplatelet peptides
10/28/1997	US5681844 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors
10/28/1997	US5681823 P1, P4 -dithio-P2 -P3 -monochloromethylene 5', 5'"-diadenosine P1, P4 -tetraphosphate as antithrombotic agent
10/28/1997	US5681821 Detecting protease in cells
10/28/1997	US5681820 Inhibition of integrins
10/28/1997	US5681819 Method and compositions for reducing cholesterol absorption
10/28/1997	US5681818 Therapeutic uses of human somatomedin carrier proteins
10/28/1997	US5681817 Treatment of ovarian estrogen dependent conditions
10/28/1997	US5681816 Administering vasoactive intestinal peptide prior and during endoscopy procedure
10/28/1997	US5681815 Antiviral and antitumor agents
10/28/1997	US5681814 Formulated IGF-I Composition
10/28/1997	US5681813 Thiodepsipeptide isolated from a marine actinomycete
10/28/1997	US5681812 Methods and compositions for reducing multidrug resistance
10/28/1997	US5681811 Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
10/28/1997	US5681810 Diphtheria toxin fragments, conjugates and methods of use to inhibit tumors and leukemia
10/28/1997	US5681809 Growth hormone antagonists
10/28/1997	US5681750 Process for preparing a C1-esterase inhibitor concentrate (C1-INH), and concentrate obtained, for therapeutic use
10/28/1997	US5681747 Nucleic acid sequences encoding protein kinase C and antisense inhibition of expression thereof
10/28/1997	US5681729 Methods for producing human lymphocytes and human monoclonal antibodies, and human monoclonal antibodies produced thereby
10/28/1997	US5681724 Parasitic helminth macrophage inhibitory factor nucleic acid molecules and uses thereof
10/28/1997	US5681723 Mutant interleukin 6 with improved biological activity over wild interleukin 6
10/28/1997	US5681722 Recombinant antibodies for human therapy
10/28/1997	US5681721 Bifunctional urokinase variants with improved fibrinolytic characteristics and thrombin inhibiting effect
10/28/1997	US5681720 DNA encoding human granulocyte colony stimulating factor plasmids and host cells comprising same, and methods of expressing the encoded polypeptide
10/28/1997	US5681719 Genetic engineering
10/28/1997	US5681714 Nucleic acid encoding tek receptor tyrosine kinase
10/28/1997	US5681700 Prognosis of nephritis by determination of presence of immunoglobulin g antibodies cross-reactive with antibodies to double stranded dna and denatured anti-a and d snrnp proteins in a lupus patient
10/28/1997	US5681589 Anticancer agents
10/28/1997	US5681587 Contacting with laminin
10/28/1997	US5681586 Heating to hydrolysis the protein in presence of protease
10/28/1997	US5681580 Plate with embossed portion electrically contacts an electrode pattern formed in a printed circuit board
10/28/1997	US5681568 Device for delivery of substances and methods of use thereof
10/28/1997	US5681566 Antibody conjugates with two or more covalently linked FC regions
10/28/1997	US5681565 Coating with immunoglobulins, antibodies
10/28/1997	US5681562 Lymphokine gene therapy of cancer
10/28/1997	US5681559 Method for producing a highly enriched population of hematopoietic stem cells
10/28/1997	US5681558 Method of using beta-interferons to treat restenosis
10/28/1997	US5681557 Use of interleukin-7 to induce monocytes/macrophages cytotoxic activity
10/28/1997	US5681556 Method and compositions for suppressing allograft rejection in mammals
10/28/1997	US5681555 Method for the treatment of bronchial asthma by parenteral administration of anionic polymers
10/28/1997	US5681541 (oligo or poly)peptides
10/25/1997	CA2203466A1 Novel specific immunophilin ligands as antiasthmatics and immunosuppressants
10/23/1997	WO1997039135A1 Enhanced expression of transgenes
10/23/1997	WO1997039133A1 Novel neuronal cell growth factor
10/23/1997	WO1997039131A1 Soluble 7-transmembrane domain g-protein-coupled receptor compositions and methods
10/23/1997	WO1997039128A2 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
10/23/1997	WO1997039127A1 Hybrid interferon compositions and methods of use
10/23/1997	WO1997039126A1 Novel rantes homolog from prostate
10/23/1997	WO1997039125A1 Antibodies against the advanced glycosylation end-product receptor and uses thereof
10/23/1997	WO1997039123A2 Secreted proteins
10/23/1997	WO1997039122A2 ISOLATED AND CLONED MAST CELL 78 kDa PHOSPHOPROTEIN (MAST CELL DEGRANULATION INHIBITORY AGENT) AND USE THEREOF
10/23/1997	WO1997039121A1 Advanced glycosylation end-product receptor peptides and uses therefor

1 ... 2676 2677 2678 2679 2680 2681 2682 2683 2684 2685 2686 2687 2688 2689 2690 2691 2692 2693 2694 2695 2696 ... 3163